YRK York Pharma

    RNS Number : 0179H
  York Pharma plc
  30 October 2008
   

    York Pharma plc

    ("York Pharma" or "the Company")

    Posting of Circular

    London, UK, 30 October 2008 York Pharma plc (AIM: YRK), the pharmaceutical company focused on the field of dermatology, announces that
further to the Company's announcement on 28 October 2008, the Company is pleased to confirm that a circular will be sent to shareholders and
the holders of AIM warrants later today containing notices convening both an extraordinary general meeting of shareholders and a general
meeting of AIM warrant holders for 27 November 2008.

    As set out in the Circular the expiry date of the warrants are being extended and Mr T I Sadler, CEO of York Pharma Plc is one of the
beneficiaries of this extension due to his holding 965,000 warrants.

    --END--

    For further information please contact:

 York Pharma plc                        Tel: +44 (0)870 067 2563 
 Terry Sadler, Chief Executive Officer

 FinnCap           Tel: +44 (0)207 600 1658 
 Stephen Norcross

 Collins Stewart Europe Limited  Tel: +44 (0)207 8000 8350 
 Nick Ellis

 Financial Dynamics        Tel: +44 (0)207 831 3113 
 David Yates
 Ben Brewerton
 Emma Thompson

    End

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
MSCIIFFTITLIVIT

York Pharma (LSE:YRK)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

York Pharma (LSE:YRK)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024